Dr Kerri Beckmann is a cancer epidemiologist with an interest in the early detection and treatment of breast, prostate and colorectal cancer. She completed her PhD at the University of Adelaide, Australia in 2014. She is employed at the University of South Australia as a Senior Research Fellow in the Cancer Epidemiology and Population Health Research Unit.
Kerri was a recipient of a Sydney Sax NHMRC Early Career Fellowship and undertook her fellowship as a Visiting Research Fellow at Kings College London working with the Translational Oncology and Urology Research Team.
Much of her current work focuses on prostate cancer outcomes research. She has had a longstanding association with the South... Read more
About me
Dr Kerri Beckmann is a cancer epidemiologist with an interest in the early detection and treatment of breast, prostate and colorectal cancer. She completed her PhD at the University of Adelaide, Australia in 2014. She is employed at the University of South Australia as a Senior Research Fellow in the Cancer Epidemiology and Population Health Research Unit.
Kerri was a recipient of a Sydney Sax NHMRC Early Career Fellowship and undertook her fellowship as a Visiting Research Fellow at Kings College London working with the Translational Oncology and Urology Research Team.
Much of her current work focuses on prostate cancer outcomes research. She has had a longstanding association with the South Australian Prostate Cancer Clinical Outcomes Collaborative and is involved in analysis of trends in clinical characteristics, treatment patterns and health outcomes using data from this clinical registry. She is also involved in other research projects the focus on patterns of care and outcomes for people affected by colorectal cancer and breast cancer.
About me
Member of the Public Health Association of Australia,Member of the Australasian Epidemiology Association
About me
| Date | Title |
|---|---|
| 09/08/2024 |
The Conversation. Many men diagnosed with prostate cancer experience poor mental health. We need to support them better, https://theconversation.com/many-men-diagnosed-with-prostate-cancer-experience-poor-mental-health-we-need-to-support-them-better-236330 |
About me
Doctor of Philosophy The University of Adelaide
Master of Public Health The University of Adelaide
Biochemistry Honours The University of Adelaide
Bachelor of Science The University of Adelaide
Current: Senior Research Fellow, Cancer Epidemiology & Population Health Research Group, UniSA, Australia
2017-2020: Visiting Research Fellow, Translational Oncology & Urology Research (TOUR), King’s College London, London UK
2015-2016: Research Fellow, Cancer Epidemiology and Population Health Research Group, UniSA, Australia
2013-2014: Research Associate, Cancer Epidemiology and Population Health Research Group, UniSA, Australia
2007-2011: Senior Research Scientist (Epidemiology), Cancer Council South Australia
1999-2006: Program Evaluation Officer, Cancer Council South Australia
1997-1998: Trainee, Victorian Public Health Training Scheme, Dept. Human Services, Victoria.
Kerri's main research area relates to determining which treatments for prostate cancer are the most effective, that is which lead to the best survival outcomes and least harm due to treatment side effects. Other areas of research interest include:1) patterns of care and outcomes in relation to breast and colorectal cancer; 2) sociodemographic disparities in presentation, treatment and outcomes; 3) evaluation of cancer screening programs; and 4) analytical methods for comparative effectiveness in assessing treatment options.
Currently, Kerri lead the SA arm of a multi-jurisdictional data-linkage project to demonstrate the value of linking clinical data with state and national administrative datasets for long-term follow-up of treatment,... Read more
Research
Excludes commercial-in-confidence projects.
Trends in survival from chronic myeloid leukaemia in Australia, Central Adelaide Local Health Network Incorporated, 01/06/2022 - 31/12/2024
Who to treat, when to treat and how to treat prostate cancer: Generating evidence to guide prostate cancer treatment decisions, NHMRC - Early Career Fellowship, 01/03/2017 - 28/02/2022
Retrospective study of SA & Monash PCA registry data investigating comparative effectiveness of treatment pathways, Cancer Council SA - Beat Cancer, 04/08/2014 - 30/11/2016
Outputs from the State-wide linked database to improve outcomes in colorectal cancer care project have highlighted service gaps which alerted healthcare providers in SA to actions required to improve patients' access and outcomes.
Her research to create the first interjurisdictional database merging data-items between SA and Victorian prostate cancer clinical registries laid the foundation for establishing the national prostate cancer register. Presentation of findings from this work showing high levels of ongoing erectile dysfunction after surgery for prostate cancer has led to more open discussion of this "silent" problem and stimulated further research to identify ways to improve post-surgical urinary and sexual functioning.
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2023 |
Open access
2
2
17
|
| 2021 |
Open access
9
8
10
|
| 2019 |
Open access
16
17
68
|
| 2019 |
Open access
13
12
19
|
| 2018 |
2
2
1
|
| Year | Output |
|---|---|
| 2024 |
Open access
34
|
| 2024 |
Open access
5
|
| 2024 |
Open access
1
1
|
| 2024 |
Open access
1
225
|
| 2024 |
Open access
2
2
|
| 2024 |
Open access
3
3
|
| 2024 |
Open access
1
1
1
|
| 2024 |
Open access
4
4
2
|
| 2023 |
Open access
2
2
17
|
| 2023 |
Open access
1
13
|
| 2023 |
Open access
1
1
|
| 2023 |
Open access
1
1
10
|
| 2023 |
Open access
5
5
1
|
| 2023 |
Open access
4
4
57
|
| 2023 |
Open access
4
4
5
|
| 2023 |
Open access
4
4
|
| 2023 |
Open access
2
2
2
|
| 2022 |
4
4
1
|
| 2022 |
Open access
5
6
28
|
| 2022 |
Open access
1
1
1
|
| 2022 |
Open access
46
42
1406
|
| 2022 |
Open access
16
15
10
|
| 2022 |
Open access
8
8
1
|
| 2021 |
Open access
12
12
7
|
| 2021 |
Open access
9
8
10
|
| 2021 |
Open access
2
4
5
|
| 2021 |
Open access
6
6
1
|
| 2021 |
3
4
|
| 2021 |
2
2
8
|
| 2021 |
Open access
9
7
2
|
| 2021 |
23
26
1
|
| 2021 |
Open access
3
2
2
|
| 2021 |
Open access
4
4
117
|
| 2020 |
15
16
14
|
| 2020 |
Open access
11
12
|
| 2020 |
Open access
8
9
14
|
| 2020 |
11
11
2
|
| 2020 |
Open access
1
1
2
|
| 2020 |
Open access
4
4
2
|
| 2020 |
Open access
28
24
66
|
| 2019 |
Open access
18
20
6
|
| 2019 |
Open access
16
17
68
|
| 2019 |
Open access
13
12
19
|
| 2019 |
Open access
10
|
| 2019 |
Open access
8
9
1
|
| 2019 |
Open access
9
12
1
|
| 2019 |
Open access
8
8
24
|
| 2019 |
Open access
171
155
841
|
| 2019 |
Open access
13
13
|
| 2018 |
2
2
1
|
| 2018 |
10
11
|
| 2018 |
9
10
|
| 2018 |
Open access
6
5
|
| 2018 |
Open access
29
27
19
|
| 2017 |
16
16
|
| 2017 |
Open access
3
3
1
|
| 2017 |
6
6
|
| 2017 |
2
|
| 2017 |
6
4
2
|
| 2017 |
18
19
1
|
| 2017 |
19
16
2
|
| 2017 |
10
9
2
|
| 2017 |
Open access
13
12
3
|
| 2017 |
Open access
4
2
1
|
| 2017 |
6
7
|
| 2017 |
Open access
10
5
1
|
| 2016 |
Open access
48
45
1
|
| 2016 |
Open access
21
22
11
|
| 2016 |
Open access
4
1
|
| 2015 |
Open access
24
23
23
|
| 2014 |
32
30
4
|
| 2014 |
Open access
8
3
|
| 2013 |
Open access
14
14
|
| 2013 |
5
6
|
| 2013 |
31
30
|
| 2012 |
37
30
|
| 2011 |
Open access
56
53
|
| 2010 |
Open access
41
39
|
| 2009 |
11
10
|
| 2009 |
Open access
2
2
|
| 2008 |
53
53
|
| 2008 |
14
15
|
| 2008 |
2
2
|
| 2008 |
30
31
|
| 2008 |
109
102
|
| 2008 |
121
109
|
| Year | Output |
|---|---|
| 2023 |
Open access
|
In work published in European Urology, Kerri and her co-authors compared the risk of additional comorbidities for men with advanced prostate cancer on two different types of hormone therapy. This publication is now available online:
Beckmann K, Garmo H, Adolfsson J, Bosco C, Johansson E, Robinson D, Holmberg L, Stattin P, Van Hemelrijck M. Androgen Deprivation Therapies and Changes in Comorbidity: A comparison of gonadotropin-releasing hormone agonists and antiandrogen monotherapy as primary therapy in men with high-risk prostate cancer. European Urology. 2018 doi: 10.1016/j.eururo.2018.11.022. [Epub ahead of print].
Currently her research exploring whether older men with prostate cancer might benefit from curative radiotherapy rather than going on hormone therapy or not receiving treatment at all. She is also researching possible explanations for why men with diabetes appear to be at lower risk of getting prostate cancer.
Research
Kerri's main research area relates to determining which treatments for prostate cancer are the most effective, that is which lead to the best survival outcomes and least harm due to treatment side effects. Other areas of research interest include:1) patterns of care and outcomes in relation to breast and colorectal cancer; 2) sociodemographic disparities in presentation, treatment and outcomes; 3) evaluation of cancer screening programs; and 4) analytical methods for comparative effectiveness in assessing treatment options.
Currently, Kerri lead the SA arm of a multi-jurisdictional data-linkage project to demonstrate the value of linking clinical data with state and national administrative datasets for long-term follow-up of treatment, outcomes and adverse effects. She is also leading a state-wide project to develop a Prostate Cancer Outcomes Report Card to inform men of likely clinical and functional outcomes following various treatments.
Kerri was the primary organiser of the Prostate Cancer Living Well After Treatment public forum in Adelaide in November 2016, which was attended by 200 men with prostate cancer, family members and friends.
Kerri has been engaged in the following committes:
External engagement & recognition
| Organisation | Country |
|---|---|
| ACT and SE NSW Breast Cancer Treatment Group | AUSTRALIA |
| ACT Health | AUSTRALIA |
| Adelaide Radiotherapy Centre | AUSTRALIA |
| Akademiska Sjukhuset | SWEDEN |
| Alfred Health | AUSTRALIA |
| American Cancer Society | UNITED STATES |
| Austin Hospital | AUSTRALIA |
| Australian Catholic University | AUSTRALIA |
| Australian National University | AUSTRALIA |
| BreastScreen SA | AUSTRALIA |
| Calvary Hospital | UNITED STATES |
| Canberra Hospital | AUSTRALIA |
| Cancer Council Australia | AUSTRALIA |
| Cancer Council of South Australia | AUSTRALIA |
| Cancer Council Queensland | AUSTRALIA |
| Cancer Council Victoria | AUSTRALIA |
| Chandlers Hill Surgery | AUSTRALIA |
| Chang Gung University | TAIWAN |
| Country Health SA | AUSTRALIA |
| Curtin University | AUSTRALIA |
| Debre Markos University | ETHIOPIA |
| Erasmus MC | NETHERLANDS |
| Erasmus MC Cancer Institute | NETHERLANDS |
| Falun Hospital | SWEDEN |
| Flinders Medical Centre | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Fondazione IRCCS Istituto Nazionale dei Tumori | ITALY |
| Fundacin Instituto Valenciano de Oncologa | SPAIN |
| Gangnam Severance Hospital | KOREA, REPUBLIC OF (SOUTH) |
| Genesis Care | AUSTRALIA |
| German Cancer Research Center | GERMANY |
| Guy’s Hospital | UNITED KINGDOM |
| Guy's and St Thomas' NHS Foundation Trust | UNITED KINGDOM |
| Guys Hospital | UNITED KINGDOM |
| Guy's Hospital | UNITED KINGDOM |
| Helsinki University Hospital | FINLAND |
| Independent Cancer Patients' Voice | UNITED KINGDOM |
| Instituto Valenciano de Oncologia | SPAIN |
| Johns Hopkins Bloomsburg School of Public Health | UNITED STATES |
| Johns Hopkins Medicine | UNITED STATES |
| Johns Hopkins University | UNITED STATES |
| Kagawa University | JAPAN |
| Kainan University | TAIWAN |
| Karalinska Institute | SWEDEN |
| Karalinska University | SWEDEN |
| Karalinska University Hospital | SWEDEN |
| Karolinska Institute | SWEDEN |
| Karolinska Institute, Sweden | SWEDEN |
| Karolinska University Hospital | SWEDEN |
| King's College London | UNITED KINGDOM |
| Kings College, VIC | AUSTRALIA |
| King's Hospital London | UNITED KINGDOM |
| Lille University Hospital Center | FRANCE |
| Lund University | SWEDEN |
| Lyell McEwin Hospital | AUSTRALIA |
| Maidstone Hospital | UNITED KINGDOM |
| Manchester University | UNITED STATES |
| Monash University | AUSTRALIA |
| National Taiwan University | TAIWAN |
| NHS Foundation Trust | UNITED KINGDOM |
| Northern Adelaide Local Health Network | AUSTRALIA |
| Norwegian University of Science and Technology | NORWAY |
| Prepatriation Hospital | AUSTRALIA |
| Private Individual | UNITED KINGDOM |
| Prostate Cancer Foundation of Australia | AUSTRALIA |
| Queen Mary University of London | UNITED KINGDOM |
| Regional Cancer Centre, Uppsala | SWEDEN |
| Repatriation General Hospital | AUSTRALIA |
| Royal Adelaide Hospital | AUSTRALIA |
| Royal Marsden Hospital | UNITED KINGDOM |
| Ryhov Hospital | SWEDEN |
| SA Health | AUSTRALIA |
| SA NT DataLink | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| Sahlgrenska University | SWEDEN |
| Sidney Kimmel Comprehensive Cancer Center | UNITED STATES |
| Singapore General Hospital | SINGAPORE |
| Skane University Hospital | SWEDEN |
| Skne University Hospital | SWEDEN |
| South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
| South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC) | AUSTRALIA |
| Southern Adelaide Local Health Network (SALHN) | AUSTRALIA |
| St John's Institute of Dermatology | UNITED KINGDOM |
| St Thomas' Hospital | UNITED KINGDOM |
| St. Thomas Hospital | UNITED STATES |
| Swinburne University of Technology | AUSTRALIA |
| Taipei City Hospital | TAIWAN |
| Taipei Medical University | TAIWAN |
| The Alfred Hospital | AUSTRALIA |
| The Cancer Council Victoria | AUSTRALIA |
| The Queen Elizabeth Hospital | AUSTRALIA |
| The Trustee for the Movember Foundation | AUSTRALIA |
| UCSF Helen Diller Family Comprehensive Cancer Center | UNITED STATES |
| Umeå Universitet | SWEDEN |
| Umea University | SWEDEN |
| Universita Degli Studi di Milano | ITALY |
| University College Dublin | IRELAND |
| University of Adelaide | AUSTRALIA |
| University of California San Francisco | UNITED STATES |
| University of Gothenburg | SWEDEN |
| University of Leeds | UNITED KINGDOM |
| University of Michigan | UNITED STATES |
| University of Newcastle | AUSTRALIA |
| University of Otago | NEW ZEALAND |
| University of Otago Dunedin School of Medicine | NEW ZEALAND |
| University of Oxford | UNITED KINGDOM |
| University of South Australia | AUSTRALIA |
| University of Southampton | UNITED KINGDOM |
| University of Sydney | AUSTRALIA |
| University of Tasmania | AUSTRALIA |
| University of Turku | FINLAND |
| University of Uppsala | SWEDEN |
| University of Western Australia | AUSTRALIA |
| University of Wollongong | AUSTRALIA |
| University of Zurich | SWITZERLAND |
| Uppsala University | SWEDEN |
| Uppsala University Hospital | SWEDEN |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
MemberAustralasian Epidemiological Association (AEA) |
2018 |
Academic AdvisorNSW Cancer Institute |
2017 |
MemberAustralasian Epidemiological Association (AEA) |
2017 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2017 |
Academic AdvisorNSW Cancer Institute |
2016 |
Best Poster AwardWorld Prostate Cancer Congress |
2016 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2016 |
Public Forum ConvenorSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2016 |
Deputy Chair, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2015 |
Early Career Researcher Networking AwardTaiwanese Cancer Screening Research Group |
2015 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2015 |
Deputy Chair, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2014 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2014 |
Deputy Chair, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2013 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2013 |
Member, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2012 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2012 |
Deputy Member, Ethics CommitteeDepartment of Health, Government of South Australia |
2011 |
Deputy Member, Steering CommitteeDataLink SA NT |
2011 |
Member, Ethics CommitteeCancer Council |
2011 |
Member, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2011 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2011 |
Deputy Member, Ethics CommitteeDepartment of Health, Government of South Australia |
2010 |
Deputy Member, Steering CommitteeDataLink SA NT |
2010 |
Member, Ethics CommitteeCancer Council |
2010 |
Member, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2010 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2010 |
Deputy Member, Ethics CommitteeDepartment of Health, Government of South Australia |
2009 |
Deputy Member, Steering CommitteeDataLink SA NT |
2009 |
Member, Ethics CommitteeCancer Council |
2009 |
Member, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2009 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2009 |
Deputy Member, Ethics CommitteeDepartment of Health, Government of South Australia |
2008 |
Member, Ethics CommitteeCancer Council |
2008 |
Member, Research CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2008 |
Member, Steering CommitteeSouth Australian Prostate Cancer Clinical Outcomes Collaborative |
2008 |
Kerri has supervised and mentored bachelors, honours and masters students in cancer and clinical epidemiology research projects. She has delivered lectures on epidemiological study designs within undergraduate and master level courses.
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Exploring the unique/unmet needs of young adult cancer survivors and access to services to address these needs | Current |
| Measuring patient reported outcomes after cancer immunotherapy | Current |
| Novel statistical analyses to reveal latent genetic architecture and to increase genomic prediction accuracy for complex diseases | Current |
| Step it up a population-based investigation of podiatry service use following neurotoxic chemotherapy | Current |
